Many science studies have confirmed the miraculous impacts of marijuana, so its limitations are now greatly decreased.
More than 85 cannabinoids are acknowledged and our nervous and digestive system has its own endocannabinoid receptors that play an significant role in our body to regulate appetite, motions, sleep, and feelings.
Terpenes are other components of cannabis that have potent pain-relieving properties. Both terpenes and cannabinoids have analgesic andanti-inflammatory properties and are easily metabolized in the human body.
Studies have shown that cannabis cannabidiol (CBD) enters the bloodstream, fastens the cannabinoid receptors in the peripheral nerves, and blocks pain signals before they reach the brain. Cannabinoids also relieve inflammation and enhance the immune system.
A different molecular structure than many cannabinoids is another non-psychoactive cannabinoid, beta Caryophyllene, which also relieves inflammation and inhibits neural pain reception..
Researchers at Michigan University discovered that chronic pain can be managed by using medical cannabis. The usage of traditional prescription pain drugs has decreased 64 per cent in patients who used the treatment, leading to fewer side effects as a result.
Legalization of medical marijuana in the United States has reduced the number of overdose deaths by 25 per cent, with 30 per cent of Americans suffering from chronic pain. Opioids are highly addictive and pose a risk of overdosing, and this has become an epidemic in the United States.
Most experts agree that medical marijuana is much better than ibuprofen, and a study involving 215 participants at the Université de Montréal showed that it led to improvements in pain, function, cognitive function and overall quality of life.
Fibromyalgia is a serious neurological disorder characterized by severe musculoskeletal pain, mood swings, fatigue, and memory and sleep problems. In most cases, antidepressants, prescription pain relievers, acetaminophen and anti-seizure medications are used.
The National Pain Foundations conducted a 2014 study that showed that marijuana helped 62 per cent of patients with fibromyalgia to treat pain and other symptoms.
Cannabinoids are usually absorbed by smoking or vaporizing cannabis, but can also be injected and applied topically.
In November 2016, a California-based company, Cannabis Science, released its “pain patch” which can be used for transdermal delivery of medical cannabis. It is promoted as a means of alleviating neuropathic pain and fibromyalgia, and when applied to the area, the skin quickly absorbs cannabis and enters the bloodstream.
The patch contains a high potency cannabinoid (CBD) extract that slowly enters the bloodstream and penetrates the central nervous system.
The company says patches promote healing in the wounded area and are much more effective than other types of medications, such as oral, topical, intravenous and intramuscular.
This is due to the fact that it provides a controlled release of the drug to the patient, usually either through a porous membrane covering the drug reservoir or through a body heat melting thin layers of medication embedded in a high potency cannabinoid (CBD) adhesive that slowly enters the bloodstream and penetrates the central nervous system.
In addition, the CEO, Mr. Raymond C. Dabney, adds that these two new pharmaceutical applications are only the tip of the iceberg when it comes to the potential use of cannabis.
He argues that they are striving to increase our land capacity for growth and facilities for producing their own products, to supply their scientists with materials to make these formulations, and at the same time they are exploring more potential needs for Cannabis-related medical applications and developing methods for delivering them. He says that they are focusing on developing pharmaceutical formulations and applications to supply the huge increase in demand expected over the next few years.
Transdermal medical cannabis patches and transdermal pens can be found in Mary’s Medicinal, Oregon, Colorado, Nevada, Michigan, Washington, and Arizona.